Akebia Therapeutics (NASDAQ:AKBA) executives outlined the company’s near- and mid-term priorities at the Leerink Partners Global Healthcare Conference, emphasizing the commercialization of its anemia ...
DXP Enterprises Inc (DXPE) reports a robust fiscal year with significant sales growth, margin expansion, and strategic acquisitions, despite challenges in supply chain services.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results